Antiphospholipid syndrome in pediatrics.

Area of Science:

• Pediatric Rheumatology
• Immunology
• Vascular Thrombosis

Background:

• Antiphospholipid syndrome (APS) is a significant cause of vascular thrombosis in children.
• Pediatric APS shares clinical features with adult APS, but lacks common adult prothrombotic factors.
• Children may have a higher prevalence of transient antiphospholipid antibodies (aPL) due to infections.

Purpose of the Study:

• To investigate the relationship between aPL and clinical manifestations in pediatric APS.
• To identify specific aPL associated with thrombosis in children.
• To understand the unique diagnostic and therapeutic challenges in childhood APS.

Main Methods:

• Establishment of an internet-based registry for pediatric patients with APS (Ped-APS Register).
• Data collection on aPL associations, clinical manifestations, treatment impact, and long-term outcomes.
• Multicenter, controlled studies are proposed for defining natural history and optimal management.

Main Results:

• Pediatric APS patients offer a unique cohort to study aPL-thrombosis relationships due to fewer confounding factors.
• The registry aims to gather crucial data on the specificities of aPL linked to pediatric thrombosis.
• Understanding transient aPL prevalence in children is key for accurate diagnosis.

Conclusions:

• The diagnostic and therapeutic approach for pediatric APS may differ from adults.
• Large, multicenter studies are essential due to the rarity of aPL-related thrombosis in children.
• The Ped-APS Register is a vital initiative for advancing knowledge and improving outcomes in childhood APS.